Skip to Content
Merck
CN
  • Stereoselective first total synthesis, confirmation of the absolute configuration and bioevaluation of botryolide-E.

Stereoselective first total synthesis, confirmation of the absolute configuration and bioevaluation of botryolide-E.

Bioorganic & medicinal chemistry letters (2011-01-08)
D Kumar Reddy, V Shekhar, P Prabhakar, D Chanti Babu, D Ramesh, B Siddhardha, U S N Murthy, Y Venkateswarlu
ABSTRACT

A simple, first stereoselective total synthesis of botryolide-E has been described. The synthesis started from propylene oxide employing Jacobsen's hydrolytic kinetic resolution (HKR), selective epoxide opening, sharpless asymmetric dihydroxylation, one pot acetonide deprotection and lactonization as key steps. Further, the synthesis confirms the absolute configuration of the natural product botryolide-E and we evaluated the biological behavior of natural product botryolide-E against a panel of bacteria and fungi. Botryolide-E exhibits significant potent activity against Staphylococcus aureus (MTCC 96) (6.25 μg/ml), good against Escherichia coli (MTCC 443) (12.5 μg/ml), Bacillus subtilis (MTCC 441) (25 μg/ml) and compound 1 exhibited good to moderate antifungal activity.

MATERIALS
Product Number
Brand
Product Description

Supelco
Nitrofurantoin, VETRANAL®, analytical standard
Sigma-Aldrich
Nitrofurantoin, 98.0-102.0% (EP, UV), meets EP testing specifications
Sigma-Aldrich
Clotrimazole